140 likes | 284 Views
"GeneScience Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2014"report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications.
E N D
Category : Pharmaceuticals & Healthcare GeneScience Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2014 Browse Complete Report - http://www.aarkstore.com/pharmaceuticals-healthcare/63684/genescience-pharmaceuticals-co-ltd-product-pipeline-review
GeneScience Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2014
Summary Global Markets Direct’s, ‘GeneScience Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2014’, provides an overview of the GeneScience Pharmaceuticals Co., Ltd.’s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of GeneScience Pharmaceuticals Co., Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. "GeneScience Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2014"report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.
Summary Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope - The report provides brief overview of GeneScience Pharmaceuticals Co., Ltd. including business description, key information and facts, and its locations and subsidiaries- The report reviews current pipeline of GeneScience Pharmaceuticals Co., Ltd.’s human therapeutic division and enlists all their major and minor projects- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones - Special feature on out-licensed and partnered product portfolio- The report summarizes all the dormant and discontinued pipeline projects- Latest company statement - Latest news and deals relating to the GeneScience Pharmaceuticals Co., Ltd.’s pipeline products
Reasons to buy - Evaluate GeneScience Pharmaceuticals Co., Ltd.’s strategic position with total access to detailed information on its product pipeline- Assess the growth potential of GeneScience Pharmaceuticals Co., Ltd. in its therapy areas of focus- Identify new drug targets and therapeutic classes in the GeneScience Pharmaceuticals Co., Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps- Develop strategic initiatives by understanding the focus areas of GeneScience Pharmaceuticals Co., Ltd. and exploit collaboration and partnership opportunities- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage- Plan mergers and acquisitions effectively by identifying the most promising pipeline of GeneScience Pharmaceuticals Co., Ltd.- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table of Content GeneScience Pharmaceuticals Co., Ltd. - Drug Profiles 11Gensci-006 11Product Description 11Mechanism of Action 11R&D Progress 11Gensci-007 12Product Description 12Mechanism of Action 12R&D Progress 12Gensci-008 13Product Description 13Mechanism of Action 13R&D Progress 13Gensci-003 14
Table of Content Product Description 14Mechanism of Action 14R&D Progress 14Gensci-028 15Product Description 15Mechanism of Action 15R&D Progress 15GeneScience Pharmaceuticals Co., Ltd. - Pipeline Analysis 16GeneScience Pharmaceuticals Co., Ltd. - Pipeline Products by Molecule Type 16GeneScience Pharmaceuticals Co., Ltd. - Dormant Projects 17GeneScience Pharmaceuticals Co., Ltd. - Locations And Subsidiaries 18Head Office 18Appendix 19Methodology 19Coverage 19Secondary Research 19
List Of Tables GeneScience Pharmaceuticals Co., Ltd., Key Information 4GeneScience Pharmaceuticals Co., Ltd., Key Facts 4GeneScience Pharmaceuticals Co., Ltd. - Pipeline by Indication, 2014 6GeneScience Pharmaceuticals Co., Ltd. - Pipeline by Stage of Development, 2014 7GeneScience Pharmaceuticals Co., Ltd. - Monotherapy Products in Pipeline, 2014 8GeneScience Pharmaceuticals Co., Ltd. - Preclinical, 2014 9GeneScience Pharmaceuticals Co., Ltd. - Unknown, 2014 10GeneScience Pharmaceuticals Co., Ltd. - Pipeline by Molecule Type, 2014 16GeneScience Pharmaceuticals Co., Ltd. - Dormant Developmental Projects,2014 17
List of Figures GeneScience Pharmaceuticals Co., Ltd. - Pipeline by Top 10 Indication, 2014 6GeneScience Pharmaceuticals Co., Ltd. - Pipeline by Stage of Development, 2014 7GeneScience Pharmaceuticals Co., Ltd. - Monotherapy Products in Pipeline, 2014 8GeneScience Pharmaceuticals Co., Ltd. - Pipeline by Top 10 Molecule Type, 2014 16
Related Reports • Global Neurosurgery Market 2015-2019 • Active Pharmaceutical Ingredients (API) Market in India 2015-2019 • BrainStorm Cell Therapeutics Inc. (BCLI) - Financial and Strategic SWOT Analysis Review • Ampio Pharmaceuticals, Inc. (AMPE) - Financial and Strategic SWOT Analysis Review • MiMedx Group, Inc (MDXG) - Financial and Strategic SWOT Analysis Review
Related Reports • Threshold Pharmaceuticals, Inc. (THLD) - Financial and Strategic SWOT Analysis Review • MEI Pharma, Inc. (MEIP) - Financial and Strategic SWOT Analysis Review • Titan Pharmaceuticals, Inc. (TTNP) - Financial and Strategic SWOT Analysis Review • RedHill Biopharma Ltd. (RDHL) - Financial and Strategic SWOT Analysis Review • Pharmaceuticals & Healthcare Market Research Reports
GeneScience Pharmaceuticals Co., Ltd. - Product Pipeline Review – 2014 Published: Oct 2014 | 20 Pages GeneScience Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2014report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications Price
Contact Us Office Office No. - 809, 8th Floor,B-Wing, Mahaavir Icon, Plot No.- 89 & 90, Sector-15,CBD-Belapur, Navi Mumbai – 400614, Maharashtra, India. Telefax No: +91 22 4127 6660 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 You Can Visit http://www.aarkstore.com OR Mail us at contact@aarkstore.com Blog : http://www.aarkstore.com/blog/ Conference : http://conference.aarkstore.com/ News : http://www.aarkstore.com/news